Global Anti Obesity Drugs Market Research Report 2021
- Published Date: 2021-03-30
- Report ID: 87094
- Pages: 118
-
Format:
Prudent Markets Predicts that Anti Obesity Drugs Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Anti Obesity Drugs Market Overview:
Global Anti Obesity Drugs Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Anti Obesity Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Anti Obesity Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Anti Obesity Drugs market in 2020.
Global Anti Obesity Drugs Market Segmentation
By Type, Anti Obesity Drugs market has been segmented into:
Orlistat
Lorcaserin
Sibutramine
Rimonabant
Exenatide
Other drugs
By Application, Anti Obesity Drugs market has been segmented into:
Application 1
Application 2
Other
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Anti Obesity Drugs market are:
Pfizer
Merck
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
1. Market Overview of Anti Obesity Drugs
1.1 Anti Obesity Drugs Market Overview
1.1.1 Anti Obesity Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Anti Obesity Drugs Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Anti Obesity Drugs Historic Market Size by Regions (2015-2020)
1.4 Anti Obesity Drugs Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Anti Obesity Drugs Sales Market by Type (2015-2026)
2.1 Global Anti Obesity Drugs Historic Market Size by Type (2015-2020)
2.2 Global Anti Obesity Drugs Forecasted Market Size by Type (2021-2026)
2.3 Orlistat
2.4 Lorcaserin
2.5 Sibutramine
2.6 Rimonabant
2.7 Exenatide
2.8 Other drugs
3. Covid-19 Impact Anti Obesity Drugs Sales Market by Application (2015-2026)
3.1 Global Anti Obesity Drugs Historic Market Size by Application (2015-2020)
3.2 Global Anti Obesity Drugs Forecasted Market Size by Application (2021-2026)
3.3 Application 1
3.4 Application 2
3.5 Other
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Anti Obesity Drugs Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Anti Obesity Drugs Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Anti Obesity Drugs Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Anti Obesity Drugs Business
5.1 Pfizer
5.1.1 Pfizer Company Profile
5.1.2 Pfizer Anti Obesity Drugs Product Specification
5.1.3 Pfizer Anti Obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Merck
5.2.1 Merck Company Profile
5.2.2 Merck Anti Obesity Drugs Product Specification
5.2.3 Merck Anti Obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Company Profile
5.3.2 GlaxoSmithKline Anti Obesity Drugs Product Specification
5.3.3 GlaxoSmithKline Anti Obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 AstraZeneca
5.4.1 AstraZeneca Company Profile
5.4.2 AstraZeneca Anti Obesity Drugs Product Specification
5.4.3 AstraZeneca Anti Obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Boehringer Ingelheim
5.5.1 Boehringer Ingelheim Company Profile
5.5.2 Boehringer Ingelheim Anti Obesity Drugs Product Specification
5.5.3 Boehringer Ingelheim Anti Obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Novo Nordisk
5.6.1 Novo Nordisk Company Profile
5.6.2 Novo Nordisk Anti Obesity Drugs Product Specification
5.6.3 Novo Nordisk Anti Obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Eisai
5.7.1 Eisai Company Profile
5.7.2 Eisai Anti Obesity Drugs Product Specification
5.7.3 Eisai Anti Obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Norgine
5.8.1 Norgine Company Profile
5.8.2 Norgine Anti Obesity Drugs Product Specification
5.8.3 Norgine Anti Obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Arena Pharmaceuticals
5.9.1 Arena Pharmaceuticals Company Profile
5.9.2 Arena Pharmaceuticals Anti Obesity Drugs Product Specification
5.9.3 Arena Pharmaceuticals Anti Obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Anti Obesity Drugs Market Size (2015-2026)
6.2 North America Anti Obesity Drugs Key Players in North America (2015-2020)
6.3 North America Anti Obesity Drugs Market Size by Type (2015-2020)
6.4 North America Anti Obesity Drugs Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Anti Obesity Drugs Market Size (2015-2026)
7.2 East Asia Anti Obesity Drugs Key Players in North America (2015-2020)
7.3 East Asia Anti Obesity Drugs Market Size by Type (2015-2020)
7.4 East Asia Anti Obesity Drugs Market Size by Application (2015-2020)
8. Europe
8.1 Europe Anti Obesity Drugs Market Size (2015-2026)
8.2 Europe Anti Obesity Drugs Key Players in North America (2015-2020)
8.3 Europe Anti Obesity Drugs Market Size by Type (2015-2020)
8.4 Europe Anti Obesity Drugs Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Anti Obesity Drugs Market Size (2015-2026)
9.2 South Asia Anti Obesity Drugs Key Players in North America (2015-2020)
9.3 South Asia Anti Obesity Drugs Market Size by Type (2015-2020)
9.4 South Asia Anti Obesity Drugs Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Anti Obesity Drugs Market Size (2015-2026)
10.2 Southeast Asia Anti Obesity Drugs Key Players in North America (2015-2020)
10.3 Southeast Asia Anti Obesity Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Anti Obesity Drugs Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Anti Obesity Drugs Market Size (2015-2026)
11.2 Middle East Anti Obesity Drugs Key Players in North America (2015-2020)
11.3 Middle East Anti Obesity Drugs Market Size by Type (2015-2020)
11.4 Middle East Anti Obesity Drugs Market Size by Application (2015-2020)
12. Africa
12.1 Africa Anti Obesity Drugs Market Size (2015-2026)
12.2 Africa Anti Obesity Drugs Key Players in North America (2015-2020)
12.3 Africa Anti Obesity Drugs Market Size by Type (2015-2020)
12.4 Africa Anti Obesity Drugs Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Anti Obesity Drugs Market Size (2015-2026)
13.2 Oceania Anti Obesity Drugs Key Players in North America (2015-2020)
13.3 Oceania Anti Obesity Drugs Market Size by Type (2015-2020)
13.4 Oceania Anti Obesity Drugs Market Size by Application (2015-2020)
14. South America
14.1 South America Anti Obesity Drugs Market Size (2015-2026)
14.2 South America Anti Obesity Drugs Key Players in North America (2015-2020)
14.3 South America Anti Obesity Drugs Market Size by Type (2015-2020)
14.4 South America Anti Obesity Drugs Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Anti Obesity Drugs Market Size (2015-2026)
15.2 Rest of the World Anti Obesity Drugs Key Players in North America (2015-2020)
15.3 Rest of the World Anti Obesity Drugs Market Size by Type (2015-2020)
15.4 Rest of the World Anti Obesity Drugs Market Size by Application (2015-2020)
16 Anti Obesity Drugs Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
